Stealth Biotherapeutics Corp ADR (MITO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MITO | BMY | AMGN | GILD | MRNA |
| Company | Stealth Biotherapeutics Corp ADR | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Moderna Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.3200 | 49.29 | 335.15 | 83.26 | 67.60 |
| High | 0.3300 | 49.53 | 338.19 | 83.76 | 67.91 |
| Low | 0.3200 | 49.06 | 334.27 | 82.75 | 65.01 |
| Last | 0.3200 | 49.21 | 335.65 | 83.12 | 65.03 |
| Change | -0.0044 | +0.19 | -0.30 | -0.78 | -2.99 |
| % Change | -1.36% | +0.39% | -0.09% | -0.93% | -4.40% |
| Volume | 1,299,700 | 6,831,721 | 1,190,813 | 3,961,205 | 2,631,520 |
| 20-Day Average Volume | 326,330 | 8,448,060 | 1,707,289 | 6,588,197 | 5,378,862 |
| Previous Close | 0.3244 | 49.02 | 335.95 | 83.90 | 68.02 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3198 | 49.18 | 330.25 | 80.45 | 74.30 |
| 20-Day Raw Stochastic | 43.50% | 59.20% | 94.40% | 84.63% | 6.05% |
| 20-Day Relative Strength | 54.62% | 55.54% | 59.13% | 69.87% | 30.55% |
| Weighted Alpha | -24.32 | -10.31 | +28.10 | +17.48 | -39.28 |
| Today's Opinion | 40% Buy | 72% Buy | 100% Buy | 88% Buy | 88% Sell |
| Previous Opinion | 40% Buy | 56% Buy | 96% Buy | 88% Buy | 88% Sell |
| Last Month's Opinion | 8% Sell | 40% Buy | 88% Buy | 56% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.65% since 11/08/22 | +0.50% since 09/13/24 | +1.63% since 09/13/24 | +0.85% since 09/13/24 | -4.32% since 09/13/24 |
| Low | 0.3200 on 11/15/22 | 48.78 on 09/18/24 | 331.00 on 09/18/24 | 82.38 on 09/17/24 | 65.20 on 09/20/24 |
| High | 0.3300 on 11/15/22 | 50.41 on 09/17/24 | 339.00 on 09/18/24 | 84.65 on 09/19/24 | 75.37 on 09/17/24 |
| 1-Month | |||||
| %Chg | +1.59% since 10/14/22 | +0.81% since 08/20/24 | +2.84% since 08/20/24 | +11.72% since 08/20/24 | -24.86% since 08/20/24 |
| Low | 0.3100 on 10/17/22 | 46.88 on 08/22/24 | 319.00 on 09/06/24 | 74.80 on 08/21/24 | 64.11 on 09/12/24 |
| High | 0.3300 on 11/15/22 | 50.75 on 09/04/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 88.59 on 08/21/24 |
| 3-Month | |||||
| %Chg | +2.89% since 08/15/22 | +20.31% since 06/20/24 | +9.03% since 06/20/24 | +21.93% since 06/20/24 | -51.39% since 06/20/24 |
| Low | 0.2911 on 08/16/22 | 39.35 on 07/05/24 | 306.11 on 07/03/24 | 66.01 on 07/05/24 | 64.11 on 09/12/24 |
| High | 0.3300 on 11/15/22 | 51.19 on 07/29/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 138.07 on 06/25/24 |
| 6-Month | |||||
| %Chg | +41.72% since 05/13/22 | -4.83% since 03/20/24 | +23.74% since 03/20/24 | +12.88% since 03/20/24 | -36.62% since 03/20/24 |
| Low | 0.1621 on 05/25/22 | 39.35 on 07/05/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 64.11 on 09/12/24 |
| High | 0.4270 on 06/08/22 | 54.47 on 03/28/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 170.47 on 05/24/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 23,537 | 99,368,440 | 180,215,344 | 104,527,072 | 26,067,982 |
| Shares Outstanding, K | 73,552 | 2,027,100 | 536,435 | 1,245,853 | 383,240 |
| Annual Sales | 0 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 6,848,000,000 |
| Annual Net Income | -52,530,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | -4,714,000,000 |
| Last Quarter Sales | 0 | 12,201,000,000 | 8,388,000,000 | 6,954,000,000 | 241,000,000 |
| Last Quarter Net Income | -8,136,000 | 1,680,000,000 | 746,000,000 | 1,614,000,000 | -1,279,000,000 |
| 60-Month Beta | 1.46 | 0.46 | 0.61 | 0.18 | 1.67 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.12 on 05/18/22 | 2.07 on 07/26/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | -3.33 on 08/01/24 |
| Latest Earnings Date | 11/17/22 | 10/31/24 | 10/29/24 | 11/05/24 | 11/07/24 |
| Most Recent Dividend | N/A | 0.600 on 07/05/24 | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 10/04/24 | 08/16/24 | 09/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 36.31 | 17.90 | 17.85 | 0.00 |